1. Home
  2. LGND vs YELP Comparison

LGND vs YELP Comparison

Compare LGND & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • YELP
  • Stock Information
  • Founded
  • LGND 1987
  • YELP 2004
  • Country
  • LGND United States
  • YELP United States
  • Employees
  • LGND N/A
  • YELP N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • YELP Other Consumer Services
  • Sector
  • LGND Health Care
  • YELP Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • YELP Nasdaq
  • Market Cap
  • LGND 2.0B
  • YELP 2.3B
  • IPO Year
  • LGND 1992
  • YELP 2012
  • Fundamental
  • Price
  • LGND $111.71
  • YELP $35.94
  • Analyst Decision
  • LGND Strong Buy
  • YELP Hold
  • Analyst Count
  • LGND 6
  • YELP 8
  • Target Price
  • LGND $144.83
  • YELP $37.00
  • AVG Volume (30 Days)
  • LGND 142.9K
  • YELP 788.0K
  • Earning Date
  • LGND 11-07-2024
  • YELP 11-07-2024
  • Dividend Yield
  • LGND N/A
  • YELP N/A
  • EPS Growth
  • LGND 160.46
  • YELP 29.71
  • EPS
  • LGND 2.47
  • YELP 1.64
  • Revenue
  • LGND $152,422,000.00
  • YELP $1,392,488,000.00
  • Revenue This Year
  • LGND $23.19
  • YELP $8.07
  • Revenue Next Year
  • LGND $15.08
  • YELP $6.30
  • P/E Ratio
  • LGND $45.20
  • YELP $21.97
  • Revenue Growth
  • LGND N/A
  • YELP 6.80
  • 52 Week Low
  • LGND $57.00
  • YELP $32.56
  • 52 Week High
  • LGND $129.90
  • YELP $48.99
  • Technical
  • Relative Strength Index (RSI)
  • LGND 48.80
  • YELP 53.91
  • Support Level
  • LGND $119.69
  • YELP $35.28
  • Resistance Level
  • LGND $125.76
  • YELP $38.49
  • Average True Range (ATR)
  • LGND 5.73
  • YELP 0.97
  • MACD
  • LGND -0.30
  • YELP 0.16
  • Stochastic Oscillator
  • LGND 25.51
  • YELP 47.42

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

Share on Social Networks: